This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kiechl, S. Articles by Bonora, E. Search for Related Content PubMed PubMed Citation Articles by Kiechl, S. Articles by Bonora, E.

(Stroke. 1998;29:900-907.)
© 1998 American Heart Association, Inc.

Original Contributions

Alcohol Consumption and Atherosclerosis: What Is the Relation?

Prospective Results From the Bruneck Study

Stefan Kiechl, MD; Johann Willeit, MD; Gregor Rungger, MD; Georg Egger, MD; Friedrich Oberhollenzer, MD; Enzo Bonora, MD; for the Bruneck Study Group

From the Department of Neurology (S.K., J.W.), Innsbruck University Clinic, Innsbruck, Austria; the Department of Internal Medicine (G.E., F.O.), Bruneck Hospital, Bruneck, Italy; and the Department of Endocrinology and Metabolism (E.B.), University of Verona, Verona, Italy.

Correspondence to Dr S. Kiechl, Department of Neurology, Innsbruck University Hospital, Anichstr. 35, A-6020 Innsbruck, Austria.

	Abstract

Top Abstract Introduction Subjects and Methods Results Discussion Appendix 1 References

 
Background and Purpose—Potential effects of regular alcohol consumption on atherogenesis are still controversial mainly due to the lack of prospective population-based studies.

Methods—The Bruneck Study is a prospective population-based survey of atherosclerosis and its risk factors. The study population comprises a sex- and age-stratified random sample of men and women aged 40 to 79 years. Participation and follow-up were more than 90% complete. Changes in carotid atherosclerosis between the 1990 baseline and the first follow-up in 1995 were monitored by high-resolution duplex ultrasonography. Alcohol intake was quantified with a standardized questionnaire and prospective diet records.

Results—Alcohol consumption less than once a week (occasional drinking) had no effect on atherogenesis. The association between regular alcohol intake and incident carotid atherosclerosis (early atherogenesis) was J-shaped, with light drinkers facing a lower risk than either heavy drinkers or abstainers. Protection offered by alcohol consumption of <50 g/d appeared to act through inhibition of the injurious action of high levels of low-density lipoprotein (LDL) cholesterol. Excess risk of incident atherosclerosis observed among heavy alcohol consumers (100 g/d) clearly surpassed the risk burden afforded by heavy smoking. The association between regular alcohol intake and incident carotid stenosis (advanced atherogenesis) was U-shaped. Odds ratios were generally shifted toward protection and did not rely on LDL cholesterol levels. We failed to find any differential effects of alcohol from various sources. All associations remained independently significant when we adjusted for lifestyle, coincidental smoking, and the metabolic complex associated with drinking.

Conclusions—Our findings support the view that adverse and beneficial effects of alcohol on arterial disease are mediated in part by a dose-dependent promotion or deceleration of atherogenesis. The protection afforded by light drinking may possibly be attributed to antithrombotic effects and inhibition of the atherogenic action of high levels of LDL cholesterol.

Key Words: alcohol drinking • atherosclerosis • carotid artery disease • lipid peroxidation • lipoproteins, LDL

	Introduction

Top Abstract Introduction Subjects and Methods Results Discussion Appendix 1 References

 
Alcohol is an important constituent of the European and American diets. The weight of previous epidemiological evidence suggests a U- or J-shaped association between alcohol consumption and various types of ischemic illness, including myocardial infarction^{1 2 3} and ischemic stroke.⁴ Low amounts of alcohol when taken on a regular basis have been shown to protect against cardiovascular disease and death,^{5 6} whereas heavy drinking constitutes a severe risk condition. Dose-dependent atherogenic and antiatherogenic properties may constitute a main pathophysiological link between alcohol consumption and arterial disease.⁷ However, this hypothesis is still challenged due to a lack of prospective epidemiological surveys in this field. The current population study may well be the first to investigate the effects of alcohol consumption on incidence and progression of atherosclerosis over a 5-year period (1990 to 1995). Our main focus was on the following questions: (1) Does the cross-sectional U-shaped association between alcohol consumption and carotid atherosclerosis observed in this cohort⁷ hold true in the prospective evaluation? If so, what is the approximate threshold for the switch from favorable to injurious effects of regular alcohol intake? (2) Which stage of atherogenesis is the main target of alcohol effects? Is it of relevance which type of alcoholic beverage is consumed and how? (3) Do putative beneficial effects of light drinking act by modifying the injurious (atherogenic) potential of LDL cholesterol, as recently postulated?⁸

	Subjects and Methods

Top Abstract Introduction Subjects and Methods Results Discussion Appendix 1 References

 
Study Subjects
Population recruitment was performed as part of the Bruneck Study.^{7 9} The survey area is located in northern Italy, in the province of Bolzano. Agriculture, tourism, commerce, and light industry are the main sources of income. Geographic remoteness causes low population mobility (<1% per year). The study population constitutes a sex- and age-stratified random sample of 1000 men and women aged 40 to 79 years (125 women and 125 men, all in the fifth to eighth decades). A total of 93.6% participated, with data assessment completed in 919 subjects. During the follow-up period between summer 1990 and 1995, a subgroup of 62 individuals died, and one moved away and could not be traced. In the remaining population, follow-up was 96.5% complete (n=826). All participants gave their informed consent before entering the study.

Clinical History
Data on alcohol consumption and drinking behavior were obtained twice in 1990 and 1995 with use of the same standardized questionnaire.⁷ Subjects were instructed to indicate their customary drinking frequency (days per week) and the average amount of alcoholic beverages ingested on a typical occasion or during a typical day. Beer (500-mL bottle, equivalent to about 25 g ethyl alcohol), white or red wine (250-mL glass, 25 g ethanol), and spirits and liqueurs (standard drink, 8 to 10 g alcohol each) were included as separate items. Average alcohol consumption was quantified in terms of grams per day and classified into four categories: (1) no regular alcohol use, (2) 50 g/d, (3) 51 to 99 g/d, and (4) 100 g/d. In addition, diet records, which resembled those developed and validated by Willett and coworkers,¹⁰ were collected as part of the follow-up evaluation. Nine frequency response categories ranged from consumption less than once a month or never to 6 times or more per day.¹⁰ Data were recorded by study subjects over the 4-week period prior to the follow-up examination, and the records were completed with the assistance of 1 specially trained physician.

The prospective analysis was restricted to men and women who either remained in the same or a neighboring category of alcohol consumption (n=780). In the latter event we calculated a weighted average of alcohol intake between 1990 and 1995, using the time intervals with consistent alcohol intake as weights, and categorized accordingly. Alternative approaches, which either applied the baseline category of alcohol intake or further excluded subjects with slight changes in alcohol quantities, yielded similar results (data not presented).

Qualitative features of drinking were derived from a structured in-person interview. According to the type of alcoholic beverage preferred, subjects were classified as (1) red wine drinkers, (2) beer drinkers (consumption of other beverages less than once a week), or (3) consumers of alcohol from other or mixed sources. Despite the high average alcohol intake in the survey area, binge drinking (defined as occasional uncontrolled ingestion of >75 to 100 g/d alcohol) was rare (<1%) and thus not considered in the analysis.

The average number of cigarettes smoked per day and the pack-years as a measure of cumulative exposure were noted for each smoker and ex-smoker. Systolic and diastolic blood pressure readings were taken with a standard mercury sphygmomanometer after at least 10 minutes of rest, while the subject was in a sitting position. The values used in the current analysis are means of three measurements taken by the same investigator at about 1-hour intervals. A standardized oral glucose tolerance test (75 g glucose in 10% solution) was performed in all subjects except those with well-established diabetes mellitus. Diabetes mellitus was coded present for subjects with fasting glucose levels of >7.8 mmol/L (140 mg/dL) and/or a 2-hour value of >11.1 mmol/L (200 mg/dL). Body mass index and waist-to-hip ratio¹¹ were used as obesity indices.

Laboratory Methods
Blood samples were taken from the antecubital vein after subjects had fasted and abstained from smoking for at least 12 hours.⁹ Apolipoproteins were measured by a nephelometric fixed-time method (apolipoproteins A1 and B, Behring; CV, 5.7% and 2.4%). HDL cholesterol and triglyceride levels were determined enzymatically (CHOD-PAP and GPO-PAP methods, Merck; CVs, 2.2% to 2.4% and 4.3% to 5.4%, respectively). LDL cholesterol was calculated with the Friedewald formula except in subjects with triglyceride levels of >4.52 mmol/L. Fasting insulin level was measured according to the method of Hales and Randle (CV, 3.2% to 4.8%) and with a human insulin–specific radioimmunoassay (Linco Research; CV, 3.9%). Lipoprotein(a) (enzyme-linked immunosorbent assay, Immuno; CV, 3.5% to 6.3%), antithrombin III (chromogenic assay, Baxter Diagnostics; CV, 2.1% to 4.9%), and fibrinogen (method of Clauss) were assessed according to standard procedures.

Scanning Protocol and Definition of Ultrasound End Points
The ultrasound protocol involves the scanning of the internal (bulbous and distal segments) and common carotid arteries (proximal and distal segments) of either side with a 10-MHz imaging probe and a 5-MHz Doppler probe.⁹ Atherosclerotic lesions were defined by two ultrasound criteria: (1) wall surface (protrusion into the lumen or roughness of the arterial boundary) and (2) wall texture (echogenicity). The maximum axial diameter of plaques, the vessel diameter in the diastole, and Doppler frequency spectra were assessed in each of the 8 vessel segments. Scanning was performed twice (in 1990 and 1995) by the same experienced sonographer, who was unaware of the subjects' clinical and laboratory characteristics. Based on the follow-up evaluation we assessed 5-year changes in the vascular status (overall progression). The scanning protocol also permitted a differentiation of various stages in atherogenesis:¹² The analysis focused on incident atherosclerosis (early atherogenesis) defined by the occurrence of new plaques in previously normal segments and on the development of vessel stenosis as a crucial event in advanced atherogenesis. The latter process was defined by a relative increase in the maximum diameter of preexisting plaques that exceeded the double measurement error of the method (distal internal carotid artery, 35%; bulbous, 30%; common carotid artery, 20%) and a resulting narrowing of the lumen of >40%. The cutoff of 40% appeared to be a biological threshold in our population, at which marked changes in growth kinetics, risk profiles, and vascular remodeling occurred, indicating a shift in the underlying pathological mechanisms from continuous step-by-step mechanisms toward occasional disease progression by plaque thrombosis.¹² This concept is substantiated by the fact that the occurrence of stenosis >40% did not rely on conventional risk factors but emerged as a domain of a procoagulant state involving high levels of fibrinogen, lipoprotein(a), and low levels of antithrombin III. Reproducibility of the ultrasound outcome categories was "nearly perfect,"¹³ as indicated by (weighted) coefficients >0.8 for agreements between double measurements (n=100).

Statistical Analysis
Agreement in alcohol quantities assessed with the standardized questionnaire or diet records was calculated using the statistics.¹³ The association between regular alcohol intake and various stages of atherogenesis was examined by logistic regression analysis, with the hypothesis test based on likelihood ratio statistics.¹⁴ The alcohol categories were modeled either as a set of indicator variables to assess the strength of association (ORs) or as a set of trends (orthogonal polynomials) to characterize the scale.¹⁴ To estimate the extent to which alcohol effects were mediated by other risk attributes, we added behavioral factors and risk factors associated with drinking to a base model that was adjusted for age and sex only. The forced entry of all covariates yielded results virtually identical to those of a forward stepwise selection procedure. Thus, for ease of presentation we present data derived from the primary simpler approach only. Effect modification was investigated by the inclusion of interaction terms.¹⁴

	Results

Top Abstract Introduction Subjects and Methods Results Discussion Appendix 1 References

 
The range of alcohol intake in our population sample was 1 to 168 g/d, whereby means for men and women amounted to 57.0 and 25.9 g/d, respectively. Distribution of alcohol categories by sex and age are given in Figure 1. Changes in the attribution to alcohol categories during follow-up can be seen in Figure 2. A vast majority of the population sample (94%) remained in the same or a neighboring category. A total of 13 subjects with moderate-to-heavy alcohol intake quit or markedly reduced drinking, and 32 increased their alcohol intake by more than 50 g/d. Alcohol quantities assessed with the standardized questionnaire or diet records were closely matched (=0.87, 1990, baseline; and =0.88, follow-up, 1995).

View larger version (39K): [in this window] [in a new window]   Figure 1. Bar graph showing alcohol consumption of various age groups and sexes (n=826).

View larger version (78K): [in this window] [in a new window]   Figure 2. Panels a and b, Changes in HDL cholesterol levels and systolic blood pressure according to changes and amounts of regular alcohol consumption during follow-up (1990 to 1995) (n=826). Panels c and d, Changes in antithrombin III and -glutamyl transferase according to changes and amounts of regular alcohol consumption during follow-up (1990 to 1995) (n=826).

As previously detailed,^{7 15} regular alcohol intake was associated with multiple changes in vascular risk factors, including an elevation of HDL cholesterol, apolipoprotein A1, systolic and diastolic blood pressures and a decrease in fibrinogen, antithrombin III, and, eventually, lipoprotein(a). We further observed an improved insulin sensitivity among alcohol consumers¹⁵ and excess rates of cigarette smoking.⁷ Other variables did not differ between abstainers and alcohol consumers. Changes in the levels of selected risk factors and -glutamyl transferase during follow-up according to changes and amounts of regular alcohol intake are given in Figure 2.

The association between regular alcohol intake and 5-year progression of carotid atherosclerosis was J-shaped, with light drinkers facing a lower risk than either abstainers or heavy alcohol consumers (n=780, Figure 3a and 3b). Excess risk of atherosclerosis observed among heavy alcohol consumers (adjusted OR, 3.41) clearly surpassed the risk burden afforded by heavy smoking (20 cigarettes/d) (OR, 2.20). Restriction of the study population to nonsmokers (n=610) yielded similar results (adjusted ORs [95% CI] for the alcohol categories: 1.0, 0.54 [0.31 to 0.93], 2.81 [1.22 to 6.05], and 3.88 [1.38 to 9.77]; P<0.001), as did the exclusion of subjects who stopped drinking before 1990 (n=34) or who experienced symptomatic cardiovascular disease (1.0, 0.65 [0.44 to 0.97], 1.85 [0.88 to 3.89], and 3.22 [1.21 to 8.57]; P=0.005).

View larger version (36K): [in this window] [in a new window]   Figure 3. A "J"- or "U"-shaped association between atherosclerosis progression and categories of regular alcohol consumption (n=780). ORs and 95% confidence intervals were derived from logistic regression analysis. *P<0.05. Adjusted for age, sex, baseline atherosclerosis, smoking, social status, physical activity, body mass index, HDL and LDL cholesterols, systolic blood pressure, lipoprotein(a), diabetes mellitus, impaired glucose tolerance, fibrinogen, antithrombin III, triglycerides, and fasting insulin. The analysis in panel 3d was restricted to subjects with preexisting carotid atherosclerosis (n=298). In panel 3b, four women who reported alcohol consumption >100 g/d were included in the 51 to 99 g/d category.

Differential effects of regular alcohol consumption on various stages of atherogenesis are visualized in Figure 3c and 3d. Notably, effects of low alcohol intake on early atherogenesis were apparently different in subjects with high (66th percentile=3.88 mmol/L; 150 mg/dL) and low-to-normal LDL cholesterol levels (adjusted ORs, 0.39 versus 1.07, P=0.009 for effect modification, Figure 3c). When these results were viewed in light of the LDL atherogenicity, high level of LDL was a prominent risk factor in abstainers and even more pronounced in moderate-to-heavy drinkers but not in light drinkers (Figure 4). Advanced atherogenesis and alcohol consumption showed a U-shaped relation (Figure 3d). ORs were generally shifted toward protection and were not influenced by LDL levels.

View larger version (11K): [in this window] [in a new window]   Figure 4. Risk of incident atherosclerosis associated with high LDL cholesterol levels (>3.88 mmol/L; 150 mg/dL) in various categories of regular alcohol consumption (n=780). The figure shows that high LDL cholesterol is a severe risk condition in abstainers, moderate drinkers, and heavy drinkers, but not in consumers of low amounts of alcohol (<50 g/d). ORs and 95% confidence intervals were derived from logistic regression analysis of incident atherosclerosis on LDL categories (>150/150 mg/dL), age, sex, baseline atherosclerosis, smoking, social status, physical activity, body mass index, HDL cholesterol, systolic blood pressure, lipoprotein(a), diabetes mellitus, impaired glucose tolerance, fibrinogen, antithrombin III, triglycerides, and fasting insulin.

Once the effect of all potential confounders had been accounted for, associations shown in Figure 3 remained unchanged in shape and emerged as independently significant. Elevated HDL cholesterol levels and improved insulin sensitivity in light drinkers accounted for an albeit small part (10%) of the inverse association with incident atherosclerosis. Application of orthogonal polynomials¹⁴ revealed a significant quadratic (P=0.012) and positive linear component (P<0.001) for the relation between alcohol and early atherogenesis and a purely quadratic type of relation for advanced atherogenesis (P=0.02).

All analyses were repeated using six equally spaced alcohol categories of 25 g/d each instead of three. This approach was more precise although less reproducible. It established upper quantitative thresholds for significant protection against early and advanced atherogeneses at 50 and 25 g/d, respectively.

All of the results shown above were not substantially different for alcohol from wine, beer, or other and mixed sources. For example, ORs for the beneficial effects of alcohol on advanced atherogenesis were 0.41, 0.48, and 0.54 for red wine, beer, and combinations of both or other beverages, respectively. Alcohol consumption during meals tended to offer more protection against advanced atherogenesis than did other types of drinking (P=0.09 for effect modification) but did not modify the relation between drinking and early atherogenesis.

Finally, ORs of incident atherosclerosis for quitters were a good match for those of current heavy drinkers (adjusted OR [95% CI], 3.75 [1.47 to 9.55]). Occasional drinking (less than once a week) affected neither early nor advanced atherogenesis (adjusted ORs, 0.97 and 1.01).

	Discussion

Top Abstract Introduction Subjects and Methods Results Discussion Appendix 1 References

 
Alcohol and Atherosclerosis: What Is the Relation?
Controversy still surrounds the role of alcohol consumption as a potential risk factor for atherogenesis.^{7 16 17 18 19 20 21} In our population-based prospective study, the association between regular alcohol intake of various quantities and 5-year progression of carotid atherosclerosis was J-shaped, with light drinkers facing a lower risk than either heavy drinkers or abstainers (Figure 3a). The relation was not materially different in men and women (Figure 3b), even though interpretation of moderate-to-heavy alcohol intake in females requires caution because of the low number of subjects in these categories. A J- or U-shaped association applied to both early and advanced atherogenesis (Figure 3c and 3d). Occasional drinking, ie, alcohol intake less than once a week, had essentially no effect on incidence and progression of atherosclerotic lesions. Our findings support the view that adverse and beneficial effects of regular alcohol consumption on arterial disease are mediated in part by a dose-dependent promotion or deceleration of atherogenesis. Alcohol-induced hypertension and excess smoking among alcohol consumers⁷ may be potentially important intermediate components in the association between moderate-to-heavy alcohol intake and atherosclerosis risk. On the other hand, the presence of an elevated HDL cholesterol level has been suggested to be of relevance in mediating the beneficial effects of light drinking.^{17 21} In our survey, when the effects of these and other risk variables were accounted for and/or smokers were excluded, the association between alcohol consumption and atherogenesis remained independently significant. Thus, our study is indicative of direct effects of alcohol and/or nonalcoholic components of wine and beer, even if some residual confounding does exist.

Previous reports on alcohol and carotid atherosclerosis are sparse and cross-sectional in design. Two small studies revealed an inverse association between carotid atherosclerosis and low alcohol intake.^{18 19} In contrast, another large cross-sectional evaluation failed to find beneficial effects of regular alcohol intake on intima-media thickening, a precursor lesion of atherosclerosis.¹⁶ As a potential explanation for these inconsistencies, it is important to note that mean alcohol consumption in the latter study was low at 3 to 10 g/d and that a considerable proportion of study subjects reported alcohol intake less than once a week (occasional drinking). Finally, in a population from the Friuli-Venezia Giulia area (northern Italy), a high lifetime load of alcohol in terms of kilograms of ethanol consumed predicted an elevated risk of prevalent carotid artery disease.²¹ In our survey, when alcohol consumption was treated as a continuous variable (grams per day), the emerging overall association with atherosclerosis progression showed a positive slope as well (data not shown).

Threshold
The weight of previous studies on cardiovascular disease reported beneficial effects of low alcohol intake up to 20 to 50 g/d ethanol, and a smaller body of evidence suggests similar thresholds for ischemic stroke.^{4 5 6 22} Corresponding limits for atherogenesis in our survey amounted to 25 to 50 g/d, depending on given stages, and thus fit well into the above range. However, all limits should be interpreted as population averages and do not necessarily reflect correct individual thresholds. Actually, intestinal degradation, absorption, metabolism, and blood clearance of ethanol are subject to high interindividual variability.

Effects of Drinking Behavior
Consumption of alcohol during meals has been postulated to offer more protection against atherosclerotic disease than other drinking patterns.^{23 24} In our population this hypothesis may hold true for effects of alcohol on advanced atherogenesis. Previous population surveys revealed that wine, beer, and spirits in moderation are all protective against cardiovascular disease.^{3 24 25} Thus far, no consistent evidence has emerged that any of these beverages is actually superior to others. The current study revealed analogous results for atherosclerosis, ie, it did not find differential effects of alcohol from various sources. This result should be viewed in light of the fact that red wine and beer accounted for 90% of overall alcohol intake in the survey area. Accordingly, results are reliable for either of these beverages but may be insufficient to settle the issue for white wine or spirits.

Pathophysiological Background
LDL Oxidation
Recently, marked inhibitory effects of nonalcoholic components of red wine on oxidation of LDL have been documented in vitro.^{26 27 28 29} Relevance of such a mechanism in vivo has been proposed,³⁰ but was initially challenged owing to the lack of precise knowledge of the pharmacokinetics of the phenolic substances.³¹ Meanwhile, an emerging body of evidence suggests that at least some are readily absorbed and that they occur in circulation at concentrations able to suppress LDL oxidation.^{30 32 33} However, beneficial effects of phenolic acids, which are contained in various amounts in all alcoholic beverages,²⁸ must be considered in the light of a potential opposite effect of ethanol. Actually, there is some experimental support for a pro-oxidant action of ethanol^{34 35} that has been ascribed to LDL modification by acetaldehyde, its primary metabolite,^{21 36} to an alcohol-induced increase in the NADH-dependent generation of free oxygen radicals,³⁷ and to mobilization of highly reactive Fe²⁺ ions.³⁸ The net impact of the consumption of alcoholic beverages on lipid peroxidation and lipid-induced atherogenesis has been postulated to dose-dependently change from protection to disease promotion.^{28 30 39} In our survey, injurious effects of high LDL levels on early atherogenesis were indeed inhibited by light drinking (<50 g/d) (Figures 3c and 4), whereas consumption of more than 50 g/d tended to further enhance the atherogenic capacity of high LDL cholesterol (P=0.009 for effect modification). Owing to the multiple analyses performed, however, we cannot rule out the possibility that this new and potentially important finding is simply a chance finding even though biological plausibility, internal consistency of the finding in sexes and different age groups (data not presented) and the emergence of a similar conjecture in a British study on alcohol intake and myocardial infarction⁸ all argue against this interpretation.

Antithrombotic Effects
In our study population, low alcohol intake halved the risk of incident carotid stenosis, most likely by counteracting plaque thrombosis. Antithrombotic effects of low amounts of alcohol are experimentally well founded: alcohol reduces thrombocyte aggregability, postprandial hypercoagulability, and activity of various coagulation factors while enhancing thrombocyte survival time and, possibly, fibrinolytic capacity.^{32 40 41 42 43 44 45} Furthermore, prostacyclin levels and the ratio of prostacyclin to thromboxane A₂ have been found to increase after low doses of ethanol.^{40 46} This observation may be relevant to atherosclerotic tissue, where a decline in prostacyclin usually predisposes to thrombus formation. Alcohol ingestion during meals tended to offer more protection, probably due to a delayed absorption and prolonged mode of action at a time when platelet reactivity increases under the influence of alimentary lipids.⁴⁷ Potential antithrombotic effects continuously leveled off beyond a threshold of 25 g/d ethanol, which was paralleled by a marked decrease in antithrombin III levels,¹⁵ a reversal of some of the antithrombotic mechanisms mentioned above, and, possibly, reactive thrombocyte hyperaggregability during periods of alcohol withdrawal ("platelet rebound"^{48 49} ).

Methodological Considerations
In the interpretation of our results it must be remembered that alcohol consumption is self-reported and is thus subject to various sources of bias.^{7 50} The nondifferential response error, which is believed to be the major source of incorrect ascertainment of alcohol consumption, has been estimated and found to be considerably low according to diet records used as a reference standard.⁷ The second important type of error, the deliberate denial of alcohol use or selective nonresponse by heavy drinkers, may also be lower than in most previous comparable studies owing to the high participation, the availability of medical records on alcohol-related diseases, and the high boundaries of socially accepted drinking in the survey area.⁷ Accuracy in the assessment of alcohol intake is further substantiated by the expected strong relation with several risk factors.^{7 15}

The category of alcohol abstainers may not represent an ideal reference group as it subsumes nondrinkers, past heavy drinkers (sick quitters),^{4 50 51} and, possibly, a few current drinkers who deny their alcohol intake. Inclusion of the latter groups could theoretically introduce a bias in terms of a pretended beneficial effect of low alcohol consumption. In the current analysis, subjects who quit drinking during follow-up were excluded before analysis. Further exclusion of subjects who stopped previously heavy drinking before 1990 did not affect any conclusion drawn from the original population sample and neither did the exclusion of "nondrinkers" with elevated -glutamyl transferase and subjects with cardiovascular disease, cancer, or cirrhosis of the liver, who may have changed drinking habits due to disease status.

Conclusions
Regular consumption of more than 50 g/d ethanol emerged as a prominent risk factor for early atherogenesis, surpassing even the effect of heavy smoking. On the other hand, low alcohol intake was beneficial in that the risk of incident vessel stenosis was cut in half. Light drinking may suppress the injurious action of high LDL levels on early atherogenesis; however, this awaits confirmation in future research.

	Selected Abbreviations and Acronyms

 

CV = coefficient of variation HDL = high-density lipoprotein LDL = low-density lipoprotein OR = odds ratio

	Appendix 1

Top Abstract Introduction Subjects and Methods Results Discussion Appendix 1 References

 
The Bruneck Study Group included Stefan Brandt, Paula Eder, Arno Gasperi, Martin Oberhollenzer, Klaus Oberlechner, and Harald Steiner at the Department of Internal Medicine and Agnes Mair and Peter Santer at the Department of Laboratory Medicine, Bruneck Hospital, Bruneck, Italy; Franz Spögler at the Department of Neurology, Brixen Hospital, Brixen, Italy; Elmar Jarosch and Maria Schober at the Department of Laboratory Medicine, Christian Wiedermann at the Department of Internal Medicine, and Franz Aichner and Werner Poewe at the Department of Neurology, Innsbruck University Hospital, Innsbruck, Austria; and Michele Muggeo at the Department of Endocrinology and Metabolism, Verona University, Verona, Italy.

	Acknowledgments

 
This research was supported in part by a grant from the Nutrition Foundation of Italy.

	Footnotes

 
See the Appendix for a list of study group members.

Received September 30, 1997; revision received February 10, 1998; accepted February 10, 1998.

	References

Top Abstract Introduction Subjects and Methods Results Discussion Appendix 1 References

 

1. Friedman LA, Kimball AW. Coronary heart disease mortality and alcohol consumption in Framingham. Am J Epidemiol. 1986;124:481–489.[Abstract/Free Full Text]
2. Maclure M. Demonstration of deductive meta-analysis: ethanol intake and risk of myocardial infarction. Epidemiol Rev. 1993;15:328–351.[Free Full Text]
3. Rimm EB, Giovannucci FL, Willett WC, Colditz GA, Ascherio A, Rosner B, Stampfer MJ. Prospective study of alcohol consumption and risk of coronary heart disease in men. Lancet. 1991;338:464–468.[Medline] [Order article via Infotrieve]
4. Camargo CA Jr. Moderate alcohol consumption and stroke: the epidemiologic evidence. Stroke. 1989;20:1611–1626.[Abstract/Free Full Text]
5. Camargo CA Jr, Hennekens CH, Gaziano JM, Glynn RJ, Manson JE, Stampfer MJ. Prospective study of moderate alcohol consumption and mortality in US male physicians. Arch Intern Med. 1997;157:79–85.[Abstract]
6. Doll R, Peto R, Hall E, Wheatley K, Gray R. Mortality in relation to consumption of alcohol. BMJ. 1994;309:911–918.[Abstract/Free Full Text]
7. Kiechl S, Willeit J, Egger G, Oberhollenzer M, Aichner F. Alcohol consumption and carotid atherosclerosis: evidence of dose-dependent atherogenic and antiatherogenic effects: results from the Bruneck study. Stroke. 1994;25:1593–1598.[Abstract]
8. Hein HO, Suadicani P, Gyntelberg F. Alcohol consumption, serum low density lipoprotein cholesterol concentration, and risk of ischaemic heart disease: six year follow up in the Copenhagen male study. BMJ. 1996;312:736–741.[Abstract/Free Full Text]
9. Willeit J, Kiechl S. Prevalence and risk factors of asymptomatic extracranial carotid artery atherosclerosis: a population-based study. Arterioscler Thromb. 1993;13:661–668.[Abstract/Free Full Text]
10. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol. 1985;122:51–65.[Abstract/Free Full Text]
11. World Health Organization. Measuring Obesity: Classification and Description of Anthropometric Data. Copenhagen, Denmark: WHO Regional Office for Europe, Nutrition Unit; 1988.
12. Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck Study. Circulation.. 1997;96:3300–3307.[Abstract/Free Full Text]
13. Landis JR, Koch GG. Measurements of observer agreement for categorical data. Biometrics. 1977;33:159–174.[Medline] [Order article via Infotrieve]
14. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York, NY: John Wiley & Sons Inc; 1988.
15. Kiechl S, Willeit J, Poewe W, Egger G, Oberhollenzer F, Muggeo M, Bonora E. Insulin sensitivity and regular alcohol consumption: large, prospective, cross sectional population study (Bruneck study). BMJ. 1996;313:1040–1044.[Abstract/Free Full Text]
16. Demirovic J, Nabulsi A, Folsom AR, Carpenter MA, Szklo M, Sorlie PD, Barnes RW. Alcohol consumption and ultrasonographically assessed carotid artery wall thickness and distensibility. Circulation. 1993;88:2787–2793.[Abstract/Free Full Text]
17. Langer RD, Criqui MH, Reed DM. Lipoproteins and blood pressure as biological pathways for effect of moderate alcohol consumption on coronary heart disease. Circulation. 1992;85:910–915.[Abstract/Free Full Text]
18. Bogousslavsky J, Van Melle G, Despland PA, Regli F. Alcohol consumption and carotid atherosclerosis in the Lausanne Stroke Registry. Stroke. 1990;21:715–720.[Abstract/Free Full Text]
19. Goldberg RJ, Burchfiel CM, Benfante R, Chiu D, Reed DM, Yano K. Lifestyle and biologic factors associated with atherosclerotic disease in middle-aged men: 20-year findings from the Honolulu Heart Program. Arch Intern Med. 1995;155:686–694.[Abstract]
20. Prati P, Vanuzzo D, Casaroli M, Di Chiara A, De Biasi f, Feruglio GA, Touboul PJ. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke. 1992;23:1705–1711.[Abstract/Free Full Text]
21. Steinberg D, Pearson TA, Kuller LH. Alcohol and atherosclerosis. Ann Intern Med. 1991;114:967–976.
22. Poikolainen K. Alcohol and mortality. J Clin Epidemiol. 1995;48:455–465.[Medline] [Order article via Infotrieve]
23. Veenstra J, Ockhuizen T, Van de Pol H, Wedel M, Schaafsma G. Effects of a moderate dose of alcohol on blood lipids and lipoproteins postprandially and in the fasting state. Alcohol Alcoholism. 1990;25:371–377.[Abstract/Free Full Text]
24. Criqui MH, Ringel BL. Does diet or alcohol explain the French paradox? Lancet. 1994;344:1719–1723.[Medline] [Order article via Infotrieve]
25. Stampfer MJ, Colditz GA, Willett WC, Speizer FE, Hennekens CH. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med. 1988;319:267–273.[Abstract]
26. Anon. Inhibition of LDL oxidation by phenolic substances in red wine: a clue to the French paradox? Nutr Rev. 1993;51:185–187.[Medline] [Order article via Infotrieve]
27. Frankel EN, Kanner J, German JB, Parks E, Kinsella JE. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet. 1993;341:454–457.[Medline] [Order article via Infotrieve]
28. Abu-Amsha R, Croft KD, Puddey IB, Proudfoot JM, Beilin LJ. Phenolic content of various beverages determines the extent of inhibition of human serum and low-density lipoprotein oxidation in vitro: identification and mechanism of action of some cinnamic acid derivatives from red wine. Clin Sci. 1996;91:449–458.[Medline] [Order article via Infotrieve]
29. Shahidi F, Wanasundara PKJ. Phenolic antioxidants. Crit Rev Food Sci Nutr. 1992;32:67–103.[Medline] [Order article via Infotrieve]
30. Fuhrman B, Lavy A, Aviram M. Consumption of red wine with meals reduces the susceptibility of human plasma and low density lipoprotein to lipid peroxidation. Am J Clin Nutr. 1995;61:549–554.[Abstract/Free Full Text]
31. Halliwell B. Antioxidants in wine. Lancet. 1993;341:1538. Letter.
32. Demrow HS, Slane PR, Folts JD. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries. Circulation. 1995;91:1182–1188.[Abstract/Free Full Text]
33. Das NP. Studies on flavonoid metabolism: absorption and metabolism of (+)-catechin in man. Biochem Pharmacol. 1971;20:3435–3445.[Medline] [Order article via Infotrieve]
34. Bjorneboe A, Bjorneboe GE. Antioxidant status and alcohol-related diseases. Alcohol Alcoholism. 1993;28:111–116.[Abstract/Free Full Text]
35. Shaish A, Pape M, Rea T, Srivastava RAK, Latour MA, Hopkins D, Schonfeld G. Alcohol increases plasma levels of cholesterol, diet-induced atherogenic lipoproteins, and aortic atherosclerosis in rabbits. Arterioscler Thromb Vasc Biol. 1997;17:1091–1097.[Abstract/Free Full Text]
36. Kesäniemi YA, Kervinen K, Miettinen TA. Acetaldehyde modification of low density lipoprotein accelerates its catabolism in man. Eur J Clin Invest. 1987;17:29–36.[Medline] [Order article via Infotrieve]
37. Dicker E, Cederbaum AI. Increased NADH-dependent production of reactive oxygen intermediates by microsomes after chronic ethanol consumption. Arch Biochem Biophysiol. 1992;293:274–280.[Medline] [Order article via Infotrieve]
38. Shaw S, Jayatilleke E. Ethanol-induced iron mobilization: role of acetaldehyde-aldehyde oxidase generated superoxide. Free Radic Biol Med. 1990;9:11–17.[Medline] [Order article via Infotrieve]
39. Croft KD, Puddey IB, Rakic V, Abu-Amsha R, Dimmitt SB, Beilin LJ. Oxidative susceptibility of low density lipoproteins: influence of regular alcohol use. Clin Exp Res. 1996;20:980–984.
40. Mikhailidis DP, Jeremy JY, Barradas MA, Green N, Dandona A. Effect of ethanol on vascular prostacyclin (prostaglandin) I₂ synthesis, platelet aggregation and platelet thromboxane release. BMJ. 1983;287:1495–1498.
41. Renaud S, Beswick AD, Fehily AM, Sharp DS, Elwood PC. Alcohol and platelet aggregation: the Caerphilly prospective heart disease study. Am J Clin Nutr. 1992;55:1012–1017.[Abstract/Free Full Text]
42. Ridker PM, Vaughan DE, Stampfer MJ, Glyn RJ, Hennekens CH. Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator. JAMA. 1994;272:929–933.[Abstract]
43. Meade TW, Chakrabarti R, Haines AP, North WRS, Stirling Y. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. BMJ. 1979;278:153–156.
44. Haut MJ, Cowan DH. The effect of ethanol on hemostatic properties of human blood platelets. Am J Med. 1974;56:22–33.[Medline] [Order article via Infotrieve]
45. Veenestra J, Wierik E, Kluft C. Alcohol and fibrinolysis. Fibrinolysis. 1990;4(suppl):64–68.
46. Landolfi R, Steiner M. Ethanol raises prostacyclin in vivo and in vitro. Blood. 1984;64:679–682.[Abstract/Free Full Text]
47. Nordoy A, Lagarde M, Renaud S. Platelets during hyperlipidaemia induced by cream and cod liver oil. Eur J Clin Invest. 1984;14:339–345.[Medline] [Order article via Infotrieve]
48. Ruf JC, Berger JL, Renaud S. Platelet rebound effect of alcohol withdrawal and wine drinking in rats: relation to tannins and lipid peroxidation. Arterioscler Thromb Vasc Biol. 1995;15:140–144.[Abstract/Free Full Text]
49. Desai K, Owen JS, Wilson DT, Hutton RA. Platelet aggregation and plasma lipoproteins in alcoholics during alcohol withdrawal. Thromb Haemost. 1986;56:173–177.
50. Alanko T. An overview of techniques and problems in the measurement of alcohol consumption. In: Smart RG, Capell HD, Glaser FB, eds. Research Advances in Alcohol and Drug Problems. New York, NY: Plenum Publishing Corp; 1984:209–226.
51. Shaper AG, Wannamethee G, Walker M. Alcohol and mortality in British men: explaining the U-shaped curve. Lancet. 1988;2:1267–1273.[Medline] [Order article via Infotrieve]

This article has been cited by other articles:

				U. Schminke, J. Luedemann, K. Berger, D. Alte, R. Mitusch, W. G. Wood, A. Jaschinski, S. Barnow, U. John, and C. Kessler Association Between Alcohol Consumption and Subclinical Carotid Atherosclerosis: The Study of Health in Pomerania Stroke, August 1, 2005; 36(8): 1746 - 1752. [Abstract] [Full Text] [PDF]

				M. BEDNARSKA-MAKARUK, M. RODO, C. MARKUSZEWSKI, A. ROZENFELD, M. SWIDERSKA, B. HABRAT, and H. WEHR POLYMORPHISMS OF APOLIPOPROTEIN E AND ANGIOTENSIN-CONVERTING ENZYME GENES AND CAROTID ATHEROSCLEROSIS IN HEAVY DRINKERS Alcohol Alcohol., July 1, 2005; 40(4): 274 - 282. [Abstract] [Full Text] [PDF]

				M. J. Pletcher, P. Varosy, C. I. Kiefe, C. E. Lewis, S. Sidney, and S. B. Hulley Alcohol Consumption, Binge Drinking, and Early Coronary Calcification: Findings from the Coronary Artery Risk Development in Young Adults (CARDIA) Study Am. J. Epidemiol., March 1, 2005; 161(5): 423 - 433. [Abstract] [Full Text] [PDF]

				M. Zureik, J. Gariepy, D. Courbon, J.-F. Dartigues, K. Ritchie, C. Tzourio, A. Alperovitch, A. Simon, and P. Ducimetiere Alcohol Consumption and Carotid Artery Structure in Older French Adults: The Three-City Study Stroke, December 1, 2004; 35(12): 2770 - 2775. [Abstract] [Full Text] [PDF]

				R. Vliegenthart, H.-H. S. Oei, A. P. M. van den Elzen, F. J. A. van Rooij, A. Hofman, M. Oudkerk, and J. C. M. Witteman Alcohol Consumption and Coronary Calcification in a General Population Arch Intern Med, November 22, 2004; 164(21): 2355 - 2360. [Abstract] [Full Text] [PDF]

				T. den Heijer, S. E Vermeer, E. J van Dijk, N. D Prins, P. J Koudstaal, C. M van Duijn, A. Hofman, and M. M. Breteler Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementia Am. J. Clinical Nutrition, October 1, 2004; 80(4): 992 - 997. [Abstract] [Full Text] [PDF]

				F. J. Charchar, M. Tomaszewski, B. Lacka, J. Zakrzewski, E. Zukowska-Szczechowska, W. Grzeszczak, and A. F. Dominiczak Association of the Human Y Chromosome with Cholesterol Levels in the General Population Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 308 - 312. [Abstract] [Full Text]

				K. J. Mukamal, R. A. Kronmal, M. A. Mittleman, D. H. O'Leary, J. F. Polak, M. Cushman, and D. S. Siscovick Alcohol Consumption and Carotid Atherosclerosis in Older Adults: The Cardiovascular Health Study Arterioscler. Thromb. Vasc. Biol., December 1, 2003; 23(12): 2252 - 2259. [Abstract] [Full Text] [PDF]

				T Laatikainen, L Manninen, K Poikolainen, and E Vartiainen Increased mortality related to heavy alcohol intake pattern J. Epidemiol. Community Health, May 1, 2003; 57(5): 379 - 384. [Abstract] [Full Text] [PDF]

				P. Jerrard-Dunne, M. Sitzer, P. Risley, D. A. Steckel, A. Buehler, S. von Kegler, and H. S. Markus Interleukin-6 Promoter Polymorphism Modulates the Effects of Heavy Alcohol Consumption on Early Carotid Artery Atherosclerosis: The Carotid Atherosclerosis Progression Study (CAPS) Stroke, February 1, 2003; 34(2): 402 - 407. [Abstract] [Full Text] [PDF]

				S. Kalmijn, M. P. J. van Boxtel, M. W. M. Verschuren, J. Jolles, and L. J. Launer Cigarette Smoking and Alcohol Consumption in Relation to Cognitive Performance in Middle Age Am. J. Epidemiol., November 15, 2002; 156(10): 936 - 944. [Abstract] [Full Text] [PDF]

				D. E. Cooper, D. C. Goff Jr., R. A. Bell, D. Zaccaro, E. J. Mayer-Davis, and A. J. Karter Is Insulin Sensitivity a Causal Intermediate in the Relationship Between Alcohol Consumption and Carotid Atherosclerosis?: The Insulin Resistance and Atherosclerosis Study Diabetes Care, August 1, 2002; 25(8): 1425 - 1431. [Abstract] [Full Text] [PDF]

				A. Avogaro, R. M. Watanabe, L. Gottardo, S. de Kreutzenberg, A. Tiengo, and G. Pacini Glucose Tolerance during Moderate Alcohol Intake: Insights on Insulin Action from Glucose/Lactate Dynamics J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1233 - 1238. [Abstract] [Full Text] [PDF]

				A. J. Grau, C. Weimar, F. Buggle, A. Heinrich, M. Goertler, S. Neumaier, J. Glahn, T. Brandt, W. Hacke, and H.-C. Diener Risk Factors, Outcome, and Treatment in Subtypes of Ischemic Stroke: The German Stroke Data Bank Stroke, November 1, 2001; 32(11): 2559 - 2566. [Abstract] [Full Text] [PDF]

				J Forsblad, A Gottsater, T Matzsch, and F Lindgarde Predictors of carotid endarterectomy in middle-aged individuals Vascular Medicine, May 1, 2001; 6(2): 81 - 85. [Abstract] [PDF]

				S. D. Wollin and P. J. H. Jones Alcohol, Red Wine and Cardiovascular Disease J. Nutr., May 1, 2001; 131(5): 1401 - 1404. [Abstract] [Full Text]